Issue
This issue is open to the public.
Alert me when new journal issues are available via or via
Editorial Board page v Full-Text PDF (35 KB)
Contents pages vii-viii Full-Text PDF (70 KB)
Reviews
Cyclin D1 in non-small cell lung cancer: A key driver of malignant transformation Oliver Gautschi, Daniel Ratschiller, Mathias Gugger, Daniel C. Betticher, Jim Heighway pages 1-14 Abstract | Full Text | Full-Text PDF (1008 KB)
Women and lung cancer: Epidemiology, tumor biology, and emerging trends in clinical research Chandra P. Belani, Sherry Marts, Joan Schiller, Mark A. Socinski pages 15-23 Abstract | Full Text | Full-Text PDF (178 KB)
Epidemiology
Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms Odilia Popanda, Lutz Edler, Peter Waas, Torsten Schattenberg, Dorota Butkiewicz, Thomas Muley, Hendrik Dienemann, Angela Risch, Helmut Bartsch, Peter Schmezer pages 25-34 Abstract | Full Text | Full-Text PDF (183 KB)
Carcinogenesis and molecular biology
Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines Malgorzata Romanowska, Keith D. Kikawa, Janet R. Fields, Anna Maciag, S. Lynn North, Yih-Horng Shiao, Kazimierz S. Kasprzak, Lucy M. Anderson pages 35-42 Abstract | Full Text | Full-Text PDF (525 KB)
Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung Yong-Woo Choi, Jin Soo Choi, Long Tai Zheng, Yun Jeong Lim, Hyoung Kyu Yoon, Yeul Hong Kim, Young-Pil Wang, Young Lim pages 43-51 Abstract | Full Text | Full-Text PDF (414 KB)
Diagnosis and pathology
Prognostic significance of vessel architecture and vascular stability in non-small cell lung cancer Niels Reinmuth, Elisabeth Piegelbrock, Miriam Raedel, Nicole Fehrmann, Heike Hintelmann, Ruth Wagner, Wolfgang E. Berdel, Michael Thomas, Lutz Freitag, Rolf M. Mesters pages 53-60 Abstract | Full Text | Full-Text PDF (1350 KB)
Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome Takamoto Saijo, Genichiro Ishii, Atsushi Ochiai, Takahiro Hasebe, Junji Yoshida, Mitsuyo Nishimura, Kanji Nagai pages 61-66 Abstract | Full Text | Full-Text PDF (996 KB)
Imaging
Clinical significance of a solitary ground-glass opacity (GGO) lesion of the lung detected by chest CT Jin-Young Oh, Sung-Youn Kwon, Ho-Il Yoon, Sang Min Lee, Jae-Joon Yim, Jae-Ho Lee, Chul-Gyu Yoo, Young Whan Kim, Sung Koo Han, Young-Soo Shim, Tae Jung Kim, Kyung Won Lee, Jin-Haeng Chung, Sang Hoon Jheon, Sook Whan Sung, Choon-Taek Lee pages 67-73 Abstract | Full Text | Full-Text PDF (1126 KB)
FDG-PET maximum standardised uptake value is associated with variation in survival: Analysis of 498 lung cancer patients Andrew Davies, Carol Tan, Christos Paschalides, Sally F. Barrington, Mike O’Doherty, Martin Utley, Tom Treasure pages 75-78 Abstract | Full Text | Full-Text PDF (190 KB)
Biological correlates of FDG uptake in non-small cell lung cancer Lioe-Fee de Geus-Oei, J. Han J.M. van Krieken, Riena P. Aliredjo, Paul F.M. Krabbe, Cathelijne Frielink, Ad F.T. Verhagen, Otto C. Boerman, Wim J.G. Oyen pages 79-87 Abstract | Full Text | Full-Text PDF (734 KB)
Treatment
Once-weekly epoetin beta (30,000IU) in anemic patients with lung cancer receiving chemotherapy Robert Pirker, Martina Lehnert, Wilma Minar pages 89-94 Abstract | Full Text | Full-Text PDF (216 KB)
Lessons to learn from EORTC study 08981: A feasibility study of induction chemoradiotherapy followed by surgical resection for stage IIIB non-small cell lung cancer V. Surmont, R.J. van Klaveren, C. Goor, F. Schramel, C. Manegold, C. Legrand, P. Van Schil, J.P. Van Meerbeeck pages 95-99 Abstract | Full Text | Full-Text PDF (134 KB)
Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: A multicenter phase II trial A.G. Pallis, Ch. Christofillakis, E. Tselepatiotis, S. Agelaki, L. Vamvakas, J. Souglakos, N. Vardakis, A. Kalykaki, A. Kotsakis, A. Argiraki, D. Mavroudis, V. Georgoulias pages 101-107 Abstract | Full Text | Full-Text PDF (264 KB)
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients Alexander Schmittel, Maren Knödler, Patricia Hortig, Karsten Schulze, Eckhard Thiel, Ulrich Keilholz pages 109-113 Abstract | Full Text | Full-Text PDF (209 KB)
Clinical correlates
Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma Junji Tsurutani, Seth M. Steinberg, Marc Ballas, Matthew Robertson, Jaclyn LoPiccolo, Hiroshi Soda, Shigeru Kohno, Valgardur Egilsson, Phillip A. Dennis pages 115-121 Abstract | Full Text | Full-Text PDF (1909 KB)
Correspondence
PET/CT imaging in response evaluation of SCLC patients Hiroaki Satoh, Morio Ohtsuka pages 123-124 Full Text | Full-Text PDF (96 KB)
Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC) Alessandra Bearz, Lucia Fratino, Simon Spazzapan, Massimiliano Berretta, Annalisa Giacalone, Cecilia Simonelli, Umberto Tirelli pages 125-127 Full Text | Full-Text PDF (103 KB)
Mutation of epidermal growth factor receptor gene in adenosquamous carcinoma of the lung Hidefumi Sasaki, Katsuhiko Endo, Haruhiro Yukiue, Yoshihiro Kobayashi, Motoki Yano, Yoshitaka Fujii pages 129-130 Abstract | Full Text | Full-Text PDF (105 KB)
Guide for Authors pages 131-134 Full-Text PDF (124 KB)
Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
